Tacrine treatment in Alzheimer's disease enhances cerebral blood flow and mental status and decreases caregiver suffering

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 472-474

  Harkins, S W ^a,b   Taylor, J R ^a   Mattay, V ^a   Regelson, W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Box 980166   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACRINE;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CAREGIVER; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; EMOTIONAL STRESS; HUMAN; LONG TERM CARE; MEMORY; MENTAL HEALTH;

EID: 0030697379     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48506.x     Document Type: Conference Paper

References (4)

1. HARKINS, S. W. & J. R. TAYLOR. 1995. Response to tacrine in patients with dementia of the Alzheimer's type: Cerebral perfusion change is related to change in mental status. Int. J. Neurosci. 84: 149-156.
2. FOLSTEIN, M. F., S. E. HOLSTEIN & P. R. MCHUGH. 1975. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psych. Res. 12: 189-198.
3. ROSEN, W. G., R. C. MOHS & K. L. DAVIS. 1984. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 141: 1356-1364.
4. MORTIMER, J. A., B. EBBITT, S. P. JUN & M. D. FINCH. 1992. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 42: 1689-1696.